Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Microbiology

Vol 9 No 2 (2024): December

Interference Between S. Aureus and P. Aeruginosa Clinical Isolates
Interferensi Antara S. Aureus dan P. Aeruginosa Isolat Klinis



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.10289
Published
October 14, 2024

Abstract

General Background: Understanding microbial interactions between Pseudomonas aeruginosa and Staphylococcus aureus is crucial for clinical infections, as they often coexist and influence each other's growth and virulence. Specific Background: Both organisms are known for their ability to form biofilms and exhibit multidrug resistance (MDR), complicating treatment strategies in hospitalized patients. Knowledge Gap: Previous studies have explored the virulence of P. aeruginosa and S. aureus, but there is limited understanding of their direct in vitro interactions, particularly in protease and lipase production. Aims: The study examined the interaction between P. aeruginosa and S. aureus isolates in hospitalized patients' sputum, urine, and blood samples, focusing on virulence factors, biofilm formation, and antibiotic resistance patterns. Results: In Diyala, Iraq, 50 clinical isolates showed P. aeruginosa as protease producers, lipase producers, and biofilm producers, with significant MDR phenotypes in both species. Novelty: This study highlights the ability of P. aeruginosa to produce staphylolysin, offering novel insights into the antagonistic mechanisms that may suppress S. aureus in co-infections. Implications: The study emphasizes the significance of understanding microbial interactions in clinical infections, particularly in biofilm-associated MDR infections, to improve treatment outcomes and guide more effective therapeutic approaches.

Highlights:

 

  1. P. aeruginosa staphylolysin inhibits S. aureus growth in vitro.
  2. Both bacteria produce biofilms and exhibit multidrug resistance.
  3. Microbial interactions impact infection severity and treatment strategies.

 

Keywords: Microbial interactions, Pseudomonas aeruginosa, Staphylococcus aureus, Biofilm, Multidrug resistance

References

  1. . M. Abd Al-Mayali and E. D. Salman, "Bacteriological and molecular study of fluoroquinolones resistance in Pseudomonas aeruginosa isolated from different clinical sources," Iraqi Journal of Science, vol. 61, no. 11, pp. 2204-2214, 2020.
  2. . M. Aghazadeh, Z. Hojabri, R. Mahdian, M. R. Nahaei, M. Rahmati, T. Hojabri, and O. Pajand, "Role of efflux pumps: MexAB-OprM and MexXY (-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients," Infection, Genetics and Evolution, vol. 24, pp. 187-192, 2014.
  3. . W. A. H. Al-Draghi and R. A. A. K. Saeed, "Synergistic effect of amikacin and ciprofloxacin on pelA and algD genes in Pseudomonas aeruginosa," Indian Journal of Forensic Medicine & Toxicology, vol. 14, no. 4, pp. 1608-1614, 2020.
  4. . E. Babapour, A. Haddadi, R. Mirnejad, S. A. Angaji, and N. Amirmozafari, "Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance," Asian Pacific Journal of Tropical Biomedicine, vol. 6, no. 6, pp. 528-533, 2016.
  5. . E. J. Baron, S. M. Finegold, and I. L. R. Peterson, Bailey and Scott's Diagnostic Microbiology, 9th ed. St. Louis, MO: Mosby, 2007.
  6. . H. G. Benson, Microbiological Applications: Laboratory Manual in General Microbiology, 8th ed. New York: McGraw-Hill, 2002.
  7. . G. Y. C. Cheung, J. S. Bae, and M. Otto, "Pathogenicity and virulence of Staphylococcus aureus," Virulence, vol. 12, no. 1, pp. 547-569, 2021.
  8. . D. Da Costa, C. Exbrayat-Héritier, B. Rambaud, S. Megy, R. Terreux, B. Verrier, and C. Primard, "Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms," Journal of Nanobiotechnology, vol. 19, pp. 1-17, 2021.
  9. . S. P. Diggle, K. Winzer, A. Lazdunski, P. Williams, and M. Camara, "Advancing the quorum in Pseudomonas aeruginosa: mvaT and the regulation of N-acetyl homoserine lactone production and virulence gene expression," Journal of Bacteriology, vol. 184, no. 10, pp. 2576-2586, 2002.
  10. . K. Ekrem and D. K. Rokan, "Antibiotic susceptibility patterns of Pseudomonas aeruginosa strains isolated from various clinical specimens," Sky Journal of Microbiology Research, vol. 2, no. 2, pp. 13-17, 2014.
  11. . C. K. Garofalo, T. M. Hooton, S. M. Martin, W. E. Stamm, J. J. Palermo, J. I. Gordon, and S. J. Hultgren, "Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation," Infection and Immunity, vol. 75, no. 1, pp. 52-60, 2007.
  12. . B. C. Haldorsen, "Aminoglycoside resistance in clinical gram-negative isolates from Norway," M.S. thesis, Universitetet i Tromsø, Tromsø, Norway, 2011.
  13. . Z. A. Hatem, S. A. Jasim, and Z. H. Mahdi, "Phenotypic and genotypic characterization of antibiotic resistance in Staphylococcus aureus isolated from different sources," Jundishapur Journal of Microbiology, vol. 14, no. 4, pp. 1-10, 2021.
  14. . V. Holá, F. Ruzicka, and M. Votava, "The dynamics of Staphylococcus epidermidis biofilm formation in relation to nutrition, temperature, and time," Scripta Medica, vol. 79, no. 3, pp. 169-174, 2006.
  15. . M. Idrees, S. Sawant, N. Karodia, and A. Rahman, "Staphylococcus aureus biofilm: Morphology, genetics, pathogenesis, and treatment strategies," International Journal of Environmental Research and Public Health, vol. 18, pp. 7602, 2021.
  16. . M. Laxmi and G. B. Sarita, "Diversity characterization of biofilm forming microorganisms in food sampled from local markets in Kochi, Kerala, India," International Journal of Recent Scientific Research, vol. 5, pp. 1070-1075, 2014.
  17. . D. Manu, I. Lupan, and O. Popescu, "Mechanisms of pathogenesis and antibiotics resistance in Escherichia coli," Annals of the Romanian Society for Cell Biology, vol. 16, no. 2, pp. 45-57, 2011.
  18. . L. S. Miller, V. G. Fowler Jr., S. K. Shukla, W. E. Rose, and R. A. Proctor, "Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms," FEMS Microbiology Reviews, vol. 44, no. 1, pp. 123-153, 2020.
  19. . M. U. Okwu, O. Mitsan, and O. P. Okeke, "Prevalence and antimicrobial susceptibility profiles of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolates among healthy individuals in Okada, South-South, Nigeria," Pharmaceutical, Biological & Chemical Sciences Journal, vol. 1, no. 1, pp. 1-9, 2014.
  20. . T. H. Rasheed, J. K. Luti, and A. M. Alaubydi, "Purification and characterization of bacteriocin from Lactobacillus acidophilus HT1 and its application in a cream formula for the treatment of some skin pathogens," Iraqi Journal of Agricultural Sciences, vol. 51, no. 5, pp. 1381-1393, 2020.
  21. . M. Saffari, S. Karami, F. Firoozeh, and M. Sehat, "Evaluation of biofilm-specific antimicrobial resistance genes in Pseudomonas aeruginosa isolates in Farabi Hospital," Journal of Medical Microbiology, vol. 66, no. 7, pp. 905-909, 2017.
  22. . S. Saxena, G. Banerjee, R. Garg, and M. Singh, "Comparative study of biofilm formation in Pseudomonas aeruginosa isolates from patients of lower respiratory tract infection," Journal of Clinical and Diagnostic Research, vol. 8, no. 5, pp. DC09-DC11, 2014.

Downloads

Download data is not yet available.